Document Detail

Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy.
MedLine Citation:
PMID:  18688134     Owner:  NLM     Status:  MEDLINE    
CONTEXT: Speech abnormalities are common to the three Parkinsonian syndromes, namely Parkinson's disease (PD), progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), the nature and severity of which is of clinical interest and diagnostic value. AIM: To evaluate the clinical pattern of speech impairment in patients with PD, PSP and MSA and to identify significant differences on quantitative speech parameters when compared to controls. DESIGN AND SETTING: Cross-sectional study conducted in a tertiary medical teaching institute. MATERIALS AND METHODS: Twenty-two patients with PD, 18 patients with PSP and 20 patients with MSA and 10 age-matched healthy controls were recruited over a period of 1.5 years. The patients were clinically evaluated for the presence and characteristics of dysarthria. This was followed by quantitative assessment of three parameters: maximum phonation time (MPT), semantic fluency and reading speed. The outcome measures were compared between the patient groups and with controls. RESULTS: Patients with PD had hypophonic monotonous speech with occasional rushes of speech while patients with MSA and PSP had mixed dysarthria with ataxic and spastic elements respectively. All quantitative parameters were affected when compared to controls (P values<0.001, 0.012 and 0.008 respectively). Maximum phonation time was significantly less in PSP when compared to MSA and PD (P=0.015). Reading speed also showed a similar trend which was not statistically significant. Semantic fluency was comparable in all three groups. CONCLUSION: Dysarthria in PD, PSP and MSA have many overlapping but certain distinctive features as well which could serve as a diagnostic clue. Patients with PSP had profound speech impairment probably indicative of the more severe frontostriatial pathology.
S Sachin; G Shukla; V Goyal; S Singh; Vijay Aggarwal; ; M Behari
Related Documents :
7027944 - Long term cognitive effects of stereotactic thalamotomy on non-parkinsonian dyskinetic ...
19672994 - Spiral analysis in niemann-pick disease type c.
11489674 - Levodopa prolongs life expectancy and is non-toxic to substantia nigra.
18688134 - Clinical speech impairment in parkinson's disease, progressive supranuclear palsy, and ...
6486674 - Experience with barbiturate therapy for cerebral protection during carotid endarterectomy.
22764184 - Troponin i in acute decompensated heart failure: insights from the ascend-hf study.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Neurology India     Volume:  56     ISSN:  0028-3886     ISO Abbreviation:  Neurol India     Publication Date:    2008 Apr-Jun
Date Detail:
Created Date:  2008-08-08     Completed Date:  2009-06-02     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0042005     Medline TA:  Neurol India     Country:  India    
Other Details:
Languages:  eng     Pagination:  122-6     Citation Subset:  IM    
Department of Neurology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110 029, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Analysis of Variance
Chi-Square Distribution
Middle Aged
Multiple System Atrophy / complications*
Parkinson Disease / complications*
Speech Disorders / etiology*
Supranuclear Palsy, Progressive / complications*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  rAAV vector-mediated gene therapy for experimental ischemic stroke.
Next Document:  Hemispherotomy for intractable epilepsy.